AtriCure reports preliminary Q4 revenue $124.3M, consensus $119.85M

AtriCure (ATRC) announced preliminary financial results for the fourth quarter and full year 2024 and provided 2025 financial guidance. Additionally, AtriCure announced that it will host an Analyst & Investor Day at its headquarters in Mason, Ohio on Wednesday, March 26. Preliminary, unaudited revenue for fourth quarter 2024 is expected to be $124.3M, reflecting growth of approximately 17% as reported and on a constant currency basis over the fourth quarter of 2023. U.S. revenue is expected to be $101.6M, reflecting growth of approximately 14%, and international revenue is expected to be $22.7M, an increase of approximately 28% as reported and on a constant currency basis.